Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Pediatric Heart Failure Clinical Trial
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
Pediatric Heart Failure Clinical Trial
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Novartis Investigator Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Pediatric Heart Failure Clinical Trial
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Novartis Investigator Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Pediatric Heart Failure Clinical Trial
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pediatric Heart Failure Clinical Trial
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pediatric Heart Failure Clinical Trial
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Heart Failure and Reduced Ejection Fraction Clinical Trial
Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Augusta, GA
Click here to add this to my saved trials
Heart Failure and Reduced Ejection Fraction Clinical Trial
Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Heart Failure and Reduced Ejection Fraction Clinical Trial
Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Heart Failure and Reduced Ejection Fraction Clinical Trial
Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Northridge, CA
Click here to add this to my saved trials
Heart Failure and Reduced Ejection Fraction Clinical Trial
Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Rocky Mount, NC
Click here to add this to my saved trials
Heart Failure and Reduced Ejection Fraction Clinical Trial
Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Saginaw, MI
Click here to add this to my saved trials
Heart Failure and Reduced Ejection Fraction Clinical Trial
Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction
Status: Enrolling, Phase IV
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Sherman, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
The Chocolate Touch Study
Status: Enrolling
Updated: 12/31/1969
ST. Luke's Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
The Chocolate Touch Study
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Obesity Clinical Trial
Eating Phenotypes for Childhood Obesity in the Context of Familial Obesity Risk
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Mild to Heavy Alcohol Consumption Clinical Trial
Cognitive, Behavioral and Aging Effects of Pain Medication in Alcohol Users
Status: Enrolling, Phase IV
Updated: 11/15/2017
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Rheumatology Clinical Trial
Secukinumab Safety and Efficacy in JPsA and ERA
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Hartford, CT
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Bradenton, FL
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigator Site
mi
from
Canton, OH
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis
mi
from
Denver, CO
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Falls Church, VA
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Kettering, OH
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Marion, OH
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Heart Failure With Preserved Ejection Fraction Clinical Trial
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
Status: Enrolling, Phase III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Fistulizing Crohn's Disease Clinical Trial
Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Clinical Research Institute
mi
from
Arlington, TX
Click here to add this to my saved trials
Fistulizing Crohn's Disease Clinical Trial
Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Fistulizing Crohn's Disease Clinical Trial
Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
San Antonio Military Medical Center
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
Fistulizing Crohn's Disease Clinical Trial
Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Gastro One
mi
from
Germantown, TN
Click here to add this to my saved trials
Fistulizing Crohn's Disease Clinical Trial
Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Indiana University Health - University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Fistulizing Crohn's Disease Clinical Trial
Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Las Vegas Medical Research
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Fistulizing Crohn's Disease Clinical Trial
Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
Gulf Region Clinical Research Institute Llc
mi
from
Pensacola, FL
Click here to add this to my saved trials
Knee Osteoarthritis Clinical Trial
Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis
Status: Enrolling, Phase II
Updated: 12/31/1969
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Chesapeake Urology Associates
mi
from
Baltimore, MD
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Novant Health Presbyterian Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Virginia Oncology Associates
mi
from
Hampton, VA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Tulane University
mi
from
New Orleans, LA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Johnston Memorial Hospital
mi
from
Smithfield, NC
Click here to add this to my saved trials
Chlamydia Trachomatis Infection Clinical Trial
Phase 2B/3 Double-blinded Placebo-controlled
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Coastal Clinical Research Inc
mi
from
Mobile, AL
Click here to add this to my saved trials
Chlamydia Trachomatis Infection Clinical Trial
Phase 2B/3 Double-blinded Placebo-controlled
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Mobile Ob-Gyn, P.C.
mi
from
Mobile, AL
Click here to add this to my saved trials
Chlamydia Trachomatis Infection Clinical Trial
Phase 2B/3 Double-blinded Placebo-controlled
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Planned Parenthood Southern New England
mi
from
New Haven, CT
Click here to add this to my saved trials
Chlamydia Trachomatis Infection Clinical Trial
Phase 2B/3 Double-blinded Placebo-controlled
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Planned Parenthood Southeastern Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Chlamydia Trachomatis Infection Clinical Trial
Phase 2B/3 Double-blinded Placebo-controlled
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Pmg Research Of Salisbury
mi
from
Salisbury, NC
Click here to add this to my saved trials
Chlamydia Trachomatis Infection Clinical Trial
Phase 2B/3 Double-blinded Placebo-controlled
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Invocare Clinical Research Center
mi
from
West Columbia, SC
Click here to add this to my saved trials
Chlamydia Trachomatis Infection Clinical Trial
Phase 2B/3 Double-blinded Placebo-controlled
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Comprehensive Clinical Trials
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Healthy Clinical Trial
Human Immunome Program
Status: Enrolling, Phase
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Solid Tumors and Lymphomas Clinical Trial
Study of the Safety and Efficacy of MIW815 With PDR001 to Patients With Advanced/Metastatic Solid Tumors or Lymphomas
Status: Enrolling, Phase I
Updated: 12/31/1969
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling, Phase III
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Michigan/ CS Mott Children's Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling, Phase III
Updated: 12/31/1969
Prevea Clinic, Inc.
mi
from
Green Bay, WI
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling, Phase III
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Neurology, Reproductive Clinical Trial
Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy
Status: Enrolling, Phase III
Updated: 12/31/1969
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Meclizine for Hepatocellular Carcinoma
Status: Enrolling, Phase I
Updated: 3/15/2018
Baylor Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Meclizine for Hepatocellular Carcinoma
Status: Enrolling, Phase I
Updated: 3/15/2018
Dan L. Duncan Cancer Center at Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Frontotemporal Dementia Clinical Trial
Intranasal Oxytocin for Frontotemporal Dementia
Status: Enrolling, Phase II
Updated: 12/31/1969
Johns Hopkins Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
CHI Health Good Samaritan
mi
from
Kearney, NE
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Regional Cancer System-Lacey
mi
from
Lacey, WA
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Northwestern Medicine Lake Forest Hospital
mi
from
Lake Forest, IL
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Anthony Hospital
mi
from
Lakewood, CO
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers-Lakewood
mi
from
Lakewood, CO
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
McLaren Greater Lansing
mi
from
Lansing, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Littleton Adventist Hospital
mi
from
Littleton, CO
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers-Longmont
mi
from
Longmont, CO
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
James Graham Brown Cancer Center, University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Jewish Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC Cancer Center at UPMC McKeesport
mi
from
McKeesport, PA
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Miami Miller School of Medicine-Sylvester Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Sinai Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Health Partners Inc
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Community Medical Hospital
mi
from
Missoula, MT
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Patrick Hospital - Community Hospital
mi
from
Missoula, MT
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
McLaren Cancer Institute-Macomb
mi
from
Mount Clemens, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Virtua Memorial
mi
from
Mount Holly, NJ
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
New Ulm Medical Center
mi
from
New Ulm, MN
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical Oncology Hematology Consultants
mi
from
Newark, DE
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Licking Memorial Hospital
mi
from
Newark, OH
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Alegent Health Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Alegent Health Lakeside Hospital
mi
from
Omaha, NE
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Pekin
mi
from
Pekin, IL
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sacred Heart Hospital
mi
from
Pensacola, FL
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare-Peoria
mi
from
Peoria, IL
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
OSF Saint Francis Radiation Oncology at Peoria Cancer Center
mi
from
Peoria, IL
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Pennsylvania:Abramson Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Southern Ohio Medical Center
mi
from
Portsmouth, OH
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente-Redwood City
mi
from
Redwood City, CA
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
North Memorial Medical Health Center
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Michigan Cancer Specialists
mi
from
Roseville, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Comprehensive Medical Center PLLC
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Norris Cotton Cancer Center-North
mi
from
Saint Johnsbury, VT
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
United Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente-San Marcos
mi
from
San Marcos, CA
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente San Rafael
mi
from
San Rafael, CA
Click here to add this to my saved trials
Clinical Trial
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente-Santa Rosa
mi
from
Santa Rosa, CA
Click here to add this to my saved trials